Harold C. Simmons Comprehensive Cancer Center
The special mission of UT Southwestern Medical Center's Harold C. Simmons Comprehensive Cancer Center is to bring new knowledge and technology to the fight against cancer through the work of our scientific programs.
Scientific Programs for Cancer Research
At Simmons Cancer Center, five complementary scientific programs serve as vehicles for discovery:
- Cancer Cell Networks
- Chemistry and Cancer
- Development and Cancer
- Experimental Therapeutics of Cancer
- Population Science and Cancer Control
Within these programs, it’s people who drive growth and progress.
The Cancer Center’s nearly 250 members are affiliated with 40 departments or centers across UT Southwestern and represent a wealth of opportunity to blend basic knowledge with translational and clinical pursuits.
Funding Sources for Research
Funding from a wide range of sources fuels a host of scientific investigations, such as collaborative, cross-disciplinary efforts with the potential to broadly impact the state of cancer knowledge and care. The work helps thousands of patients every year at Simmons Cancer Center clinics, including a growing number of people receiving the latest in cancer care through clinical trials.
Simmons Cancer Center currently has 40 investigator-initiated clinical trials – more than any other cancer center in North Texas.
In the Community
Simmons Cancer Center is also pushing forward and outward into the community, building and improving laboratories to disseminate discoveries related to cancer prevention and detection, especially among the medically underserved.
For example, a new, National Cancer Institute-funded community partnership called PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) is exploring how best to ensure regular colon cancer screenings.
In addition, a robust cancer genetics program is reaching out to ensure that patients and families with an elevated hereditary risk of colon and uterine cancers, as well as those with gene mutations linked to breast and ovarian cancers, are alerted and closely monitored.
Such wheels of progress promise to generate
advances for decades to come. Those advances will improve the state of science
not just at Simmons Cancer Center but also throughout
Texas and the nation.